Top Markets
Coin of the day
ZyVersa Therapeutics, Inc. ZyVersa Therapeutics, Inc.

ZyVersa Therapeutics, Inc.

ZVSA
Rank in Stocks #38791
ZyVersa Therapeutics, Inc. is a biopharmaceutical firm in its clinical... ZyVersa Therapeutics, Inc. is a biopharmaceutical firm in its clinical development phase, dedicated to advancing and commercializing therapies for renal (kidney) and inflammatory disorders. The company's pipeline prominently features VAR 200, a cholesterol efflux modulator aimed at addressing kidney diseases such as focal segmental glomerulosclerosis, Alport syndrome, and diabetic kidney disease. Furthermore, ZyVersa is advancing IC 100, a pioneering inflammasome ASC inhibitor positioned to tackle a wide array of inflammatory conditions. The company maintains its corporate headquarters in Weston, Florida.
Share Price
$0.099
Market Cap
$801.50K
Change (1 day)
0.00%
Change (1 year)
-34.44%
Country
US
Trade ZyVersa Therapeutics, Inc. (ZVSA)

Category

Stock split history for ZyVersa Therapeutics, Inc. (ZVSA)
ZyVersa Therapeutics, Inc. stock (symbol: ZVSA) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 14, 2026.
One ZVSA share bought prior to Aug 14, 2026 would equal to 0 ZVSA shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE